Viridian Therapeutic (VRDN) PT Lowered to $20 at Wells Fargo
Tweet
Share
E-mailGet Alerts VRDN Hot Sheet
Price: $17.28 -1.99%
Rating Summary:
15 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Rating Summary:
15 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Join SI Premium – FREE
Wells Fargo analyst Derek Archila lowered the price target on Viridian Therapeutic (NASDAQ: VRDN) to $20.00 (from $29.00) while maintaining a Equal Weight rating.
You May Also Be Interested In
- Natera (NTRA) PT Raised to $270 at BTIG
- ChargePoint Holdings Inc. (CHPT) PT Raised to $8 at UBS as Cost Discipline Improves
- United Airlines (UAL) PT Raised to $153 at UBS Ahead of Q2 Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
